February 01, 2008
WEST SACRAMENTO, Calif., Feb. 4, 2008 - Lipomics Technologies, Inc., a privately held company that
specializes in clinical diagnostic development, announced today that it is engaged in a research
collaboration with Joslin Diabetes Center.
The collaboration will initially focus on two research programs. The first is a study on insulin resistant
patients with a family history of type 2 diabetes. The primary objective is to identify predictive markers of
disease that can be translated into blood based diagnostics.
The second study will focus on understanding the effects of gastric bypass surgery on insulin sensitivity.
Both research programs originate from the laboratories of Mary Elizabeth Patti, MD, and Allison Goldfine,
both Assistant Professors of Medicine, at Harvard Medical School and Investigators at Joslin Diabetes
Center.
“We are excited about this collaboration and anticipate that the unique technology at Lipomics will generate
interesting results and advance our research programs, as we believe that lipid metabolism is a critical
component of diabetes risk” said Dr. Patti.
Lipomics is developing diagnostic monitoring tools for the management of type 2 diabetes. “It is an honor
to work with Dr. Patti and a premier research institution like the Joslin Diabetes Center. We believe that this
collaboration will provide access to valuable clinical samples in support of our diagnostic development
programs” said Steve Watkins, Ph.D., chief executive officer at Lipomics.
Lipomics will retain certain rights to develop diagnostic applications based on data emerging from these
studies.
About Joslin Diabetes Center
Joslin Diabetes Center is the world’s largest diabetes clinic, diabetes research center and provider
of diabetes education. Founded in 1898, Joslin is an independent nonprofit institution affiliated
with Harvard Medical School. Joslin research is a team of more than 300 people at the forefront of
discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel
Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and
the hundreds of Joslin educational programs offered each year for clinicians, researchers and
patients, enable Joslin to develop, implement and share innovations that immeasurably improve the
lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in
advancing its mission. For more information on Joslin, call 1-800-JOSLIN-1 or visit
www.joslin.org.